Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Pharmaceutical Sciences
|
May 10, 2013
Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs
Shunsuke Ozaki, Ikuo Kushida, Taro Yamashita, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 11, 2006
Reliable on-line sample preparation of basic compounds from plasma using a reversed phase restricted access media in column-switching LC
Eiichi Yamamoto, Hatsue Igarashi, Yoshiaki Sato, et al.
Bioorganic & Medicinal Chemistry
|
October 1, 2014
Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe, et al.
Cancer Research
|
January 7, 2021
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
Kazuhiko Yamada, Yusaku Hori, Satoshi Inoue, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Pharmaceutical Sciences
|
May 10, 2013
Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs
Shunsuke Ozaki, Ikuo Kushida, Taro Yamashita, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 11, 2006
Reliable on-line sample preparation of basic compounds from plasma using a reversed phase restricted access media in column-switching LC
Eiichi Yamamoto, Hatsue Igarashi, Yoshiaki Sato, et al.
Bioorganic & Medicinal Chemistry
|
October 1, 2014
Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe, et al.
Cancer Research
|
January 7, 2021
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
Kazuhiko Yamada, Yusaku Hori, Satoshi Inoue, et al.
Page
of 2